Featured Research Search Results

SCREEN-CUP: Menstrual Cup Screening for Endometrial Cancer in Lynch Syndrome

Clinicaltrials.gov identifier:
NCT07220239

Prevention
Screening study for endometrial cancer

An Early Detection and Prevention Study for People with an Increased Risk of Cancer (InAdvance)

Clinicaltrials.gov identifier:
NCT05463796

Prevention
Study for people at risk of cancer, including previvors, survivors and family members

Genetic Testing for Cancer Risk for Black Families in Texas

Clinicaltrials.gov identifier:
NCT05694559

Prevention
Study to improve genetic counseling and testing to Black families in Texas

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Clinicaltrials.gov identifier:
NCT06195306

Prevention
Phase 2 study for overweight postmenopausal women at increased risk for breast cancer

Comparing an Experimental Drug Puxi-Sam with Standard Chemotherapy for Metastatic Endometrial Cancer (Bluestar‑Endometrial01)

Clinicaltrials.gov identifier:
NCT07044336

Treatment
Phase 3 treatment study for metastatic endometrial cancer

Treating Advanced Solid Tumors with Targeted Therapies Called RAS(ON) Inhibitors Combined With the Targeted Immunotherapy Ivonescimab

Clinicaltrials.gov identifier:
NCT07397338

Treatment
Phase 1/2 treatment study for solid tumors with a RAS mutation

The EASE Study: Helping People with Advanced Cancer Cope with Fear of Cancer Progression

Clinicaltrials.gov identifier:
NCT07636200

Quality of Life
Quality of life study for people with advanced cancer experiencing anxiety

Perceptions of Gastric Cancer Risk and Attitudes Toward Endoscopic Surveillance in People with CDH1 or CTNNA1 Mutations

Surveys, Registries, Interviews
Online survey about gastric cancer risk and medical decision-making for people with an inherited CDH1 or CTNNA1 pathogenic variant

Treating Advanced Solid Tumors with a KRAS G12C Mutation Using Targeted Therapies Called RAS(ON) Inhibitors

Clinicaltrials.gov identifier:
NCT06128551

Treatment
Phase 1/2 treatment study for advanced colorectal, pancreatic or lung cancer with a KRAS G12C mutation

Testing a KRAS Vaccine with Immunotherapy for Advanced Pancreatic and Colorectal Cancers with MMR‑Proficient (MMR‑p) Tumors

Clinicaltrials.gov identifier:
NCT06411691

Treatment
Phase 1b treatment study for previously-treated pancreatic or colorectal cancer with a KRAS mutation

A Study of Fallopian Tube Removal with Delayed Ovary Removal to Lower Ovarian Cancer Risk (TUBA-WISP-II)

Clinicaltrials.gov identifier:
NCT04294927

Prevention
Prevention study for women at high risk for ovarian cancer

Comparing Hormone Therapy With and Without Chemotherapy for Premenopausal Breast Cancer (OFSET)

Clinicaltrials.gov identifier:
NCT05879926

Treatment
Phase 3 study for premenopausal, early-stage, ER positive, HER2-negative breast cancer

Treating Recurrent dMMR or MSI-High Endometrial Cancer with the Immunotherapy Drug, Nivolumab with or without the Immunotherapy Drug, Ipilimumab

Clinicaltrials.gov identifier:
NCT05112601

Treatment
Phase 2 treatment study for recurrent endometrial cancer with dMMR or MSI-High biomarker

Using a Shorter Type of MRI as a Screening Tool for People at High Risk for Prostate Cancer

Clinicaltrials.gov identifier:
NCT05384535

Prevention
Screening for people at high risk for prostate cancer

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

Clinicaltrials.gov identifier:
NCT05926102

Prevention
Prostate cancer screening study for male US veterans age 55–69

Understanding Access to Genetic Services for Latina Women with Breast Cancer

Surveys, Registries, Interviews
A phone survey for Latina breast cancer survivors diagnosed within the past five years in California

Treating Advanced Breast or Other Solid Cancers Using a Combination of a New Targeted Therapy, ZEN003694, With The Targeted Therapy Abemaciclib (Verzenio)

Clinicaltrials.gov identifier:
NCT05372640

Treatment
Phase 1 treatment study for advanced breast cancer and other solid tumors

Study of a New Targeted Therapy Given Alone or in Combination with an Immunotherapy for Metastatic, Triple-Negative Breast Cancer

Clinicaltrials.gov identifier:
NCT06841354

Treatment
Phase 3 treatment study for people with metastatic, triple-negative breast cancer